openPR Logo
Press release

Hepatic Encephalopathy Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Salix Pharma, Bausch Health, Axcella Health, Umecrine Cognition, Vedanta Biosciences

03-26-2025 03:24 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Hepatic Encephalopathy Market to Show Remarkable Growth Trends

The Key Hepatic Encephalopathy Companies in the market include - Salix Pharmaceuticals, Bausch Health, Axcella Health, Umecrine Cognition, Vedanta Biosciences, Bausch Health Americas, Inc., Ocera Therapeutics, Horizon Pharma, Mallinckrodt, and others.

DelveInsight's "Hepatic Encephalopathy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Hepatic Encephalopathy, historical and forecasted epidemiology as well as the Hepatic Encephalopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Hepatic Encephalopathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hepatic Encephalopathy Market Forecast [https://www.delveinsight.com/sample-request/hepatic-encephalopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Hepatic Encephalopathy Market Report:

*
The Hepatic Encephalopathy market size was valued ~USD 1,680 Million in the year 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)

*
In 2023, Germany held the largest market share among the EU4 and the UK, accounting for 31%, while Spain had the smallest share, representing 10%.

*
In November 2024, Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company utilizing its proprietary technology platform to enhance therapeutics via efficient oral delivery, announced the publication and discussion of a manuscript titled "Oral LPCN 1148 Improves Sarcopenia and Hepatic Encephalopathy in Male Patients with Cirrhosis: A Randomized, Placebo-Controlled Phase 2 Triall

*
The total number of diagnosed prevalent cases of hepatic encephalopathy in the US is projected to rise significantly, with a notable compound annual growth rate (CAGR) by 2034, starting from approximately 209,000 cases in 2023.

*
In 2023, the UK had the highest diagnosed prevalent population of hepatic encephalopathy among European countries, accounting for 28%, followed by Germany. Conversely, Spain had the lowest diagnosed prevalence, representing about 9% of hepatic encephalopathy cases that year.

*
In Japan, the majority of diagnosed hepatic encephalopathy cases in 2023 were of covert hepatic encephalopathy, with approximately 17.7 thousand cases. Meanwhile, overt hepatic encephalopathy accounted for around 11.8 thousand cases during the same year.

*
Key Hepatic Encephalopathy Companies: Salix Pharmaceuticals, Bausch Health, Axcella Health, Umecrine Cognition, Vedanta Biosciences, Bausch Health Americas, Inc., Ocera Therapeutics, Horizon Pharma, Mallinckrodt, and others

*
Key Hepatic Encephalopathy Therapies: Xifaxan (Rifaximin/OHE7), Golexanolone, Rifaximin (SSD), AXA1665, GR3027 (Golexanolone), VE303, Rifaximin, AST-120, HPN-100, MNK6106, and others

*
The Hepatic Encephalopathy epidemiology based on gender analyzed that out of the total diagnosed prevalent cases of Hepatic Encephalopathy, in the United States, 72.70% were occupied by males

*
The Hepatic Encephalopathy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hepatic Encephalopathy pipeline products will significantly revolutionize the Hepatic Encephalopathy market dynamics.

Hepatic Encephalopathy Overview

Hepatic encephalopathy (HE) is a condition characterized by neurological abnormalities that occur as a complication of liver dysfunction or liver disease.

Get a Free sample for the Hepatic Encephalopathy Market Report:

https://www.delveinsight.com/report-store/hepatic-encephalopathy-market [https://www.delveinsight.com/report-store/hepatic-encephalopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Hepatic Encephalopathy Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Hepatic Encephalopathy Epidemiology Segmentation:

The Hepatic Encephalopathy market report proffers epidemiological analysis for the study period 2020-2032ain the 7MM segmented into:

*
Total Prevalence of Hepatic Encephalopathy

*
Prevalent Cases of Hepatic Encephalopathy by severity

*
Gender-specific Prevalence of Hepatic Encephalopathy

*
Diagnosed Cases of Episodic and Chronic Hepatic Encephalopathy

Download the report to understand which factors are driving Hepatic Encephalopathy epidemiology trends @ Hepatic Encephalopathy Epidemiology Forecast [https://www.delveinsight.com/sample-request/hepatic-encephalopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Hepatic Encephalopathy Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hepatic Encephalopathy market or expected to get launched during the study period. The analysis covers Hepatic Encephalopathy market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Hepatic Encephalopathy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Hepatic Encephalopathy Therapies and Key Companies

*
Xifaxan (Rifaximin/OHE7): Salix Pharmaceuticals/Bausch Health

*
Golexanolone: Umecrine Cognition AB

*
Rifaximin (SSD): Salix Pharmaceuticals/Bausch Health

*
AXA1665: Axcella Health

*
GR3027 (Golexanolone): Umecrine Cognition

*
VE303: Vedanta Biosciences

*
Rifaximin: Bausch Health Americas, Inc.

*
AST-120: Ocera Therapeutics

*
HPN-100: Horizon Pharma

*
MNK6106: Mallinckrodt

Discover more about therapies set to grab major Hepatic Encephalopathy market share @ Hepatic Encephalopathy Treatment Market [https://www.delveinsight.com/sample-request/hepatic-encephalopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Hepatic Encephalopathy Market Drivers

*
Increasing diagnosed prevalence of Hepatic Encephalopathy

*
Emergence in novel treatment target

*
Less competition among therapies

Hepatic Encephalopathy Market Barriers

*
Adverse events associated with the current therapies

*
The pipeline not very robust

*
Disease burden

*
Challenges in the diagnosis of disease

Scope of the Hepatic Encephalopathy Market Report

*
Study Period: 2020-2034

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Hepatic Encephalopathy Companies: Salix Pharmaceuticals, Bausch Health, Axcella Health, Umecrine Cognition, Vedanta Biosciences, Bausch Health Americas, Inc., Ocera Therapeutics, Horizon Pharma, Mallinckrodt, and others

*
Key Hepatic Encephalopathy Therapies: Xifaxan (Rifaximin/OHE7), Golexanolone, Rifaximin (SSD), AXA1665, GR3027 (Golexanolone), VE303, Rifaximin, AST-120, HPN-100, MNK6106, and others

*
Hepatic Encephalopathy Therapeutic Assessment: Hepatic Encephalopathy current marketed and Hepatic Encephalopathy emerging therapies

*
Hepatic Encephalopathy Market Dynamics: Hepatic Encephalopathy market drivers and Hepatic Encephalopathy market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Hepatic Encephalopathy Unmet Needs, KOL's views, Analyst's views, Hepatic Encephalopathy Market Access and Reimbursement

To know more about Hepatic Encephalopathy companies working in the treatment market, visit @ Hepatic Encephalopathy Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/hepatic-encephalopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Hepatic Encephalopathy Market Report Introduction

2. Executive Summary for Hepatic Encephalopathy

3. SWOT analysis of Hepatic Encephalopathy

4. Hepatic Encephalopathy Patient Share (%) Overview at a Glance

5. Hepatic Encephalopathy Market Overview at a Glance

6. Hepatic Encephalopathy Disease Background and Overview

7. Hepatic Encephalopathy Epidemiology and Patient Population

8. Country-Specific Patient Population of Hepatic Encephalopathy

9. Hepatic Encephalopathy Current Treatment and Medical Practices

10. Hepatic Encephalopathy Unmet Needs

11. Hepatic Encephalopathy Emerging Therapies

12. Hepatic Encephalopathy Market Outlook

13. Country-Wise Hepatic Encephalopathy Market Analysis (2020-2034)

14. Hepatic Encephalopathy Market Access and Reimbursement of Therapies

15. Hepatic Encephalopathy Market Drivers

16. Hepatic Encephalopathy Market Barriers

17. Hepatic Encephalopathy Appendix

18. Hepatic Encephalopathy Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hepatic-encephalopathy-market-to-show-remarkable-growth-trends-from-2024-to-2034-delveinsight-reports-salix-pharma-bausch-health-axcella-health-umecrine-cognition-vedanta-biosciences]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hepatic Encephalopathy Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Salix Pharma, Bausch Health, Axcella Health, Umecrine Cognition, Vedanta Biosciences here

News-ID: 3939880 • Views:

More Releases from ABNewswire

Understanding Magnetic Switches: Types, Working Principles, and Applications
Understanding Magnetic Switches: Types, Working Principles, and Applications
A magnetic switch is a versatile electrical device that operates by responding to magnetic fields. From Hall Effect to reed switches, explore their functions, types, and diverse applications. What is a Magnetic Switch? A magnetic switch is an electrical device that operates by responding to the presence of a magnetic field. It functions by closing or opening its contacts based on the strength of the magnetic field. Specifically, the switch remains closed
Innovating embedded downlight technology: Leading the global trend of intelligent, efficient and customized lighting
Innovating embedded downlight technology: Leading the global trend of intelligen …
The strong rise of China's manufacturing industry has profoundly reshaped the technological landscape and development trajectory of embedded downlights. With its unparalleled industrial chain advantages, continuous technological innovation, and significant cost-effectiveness, Chinese enterprises have risen from participants in the global lighting industry to undisputed leaders. This transformation goes far beyond the huge production scale; it lies in the thorough innovation of the core technical content and application boundaries of embedded
North China Electric Power University Foreign Aid Training Program Visits Yiyuan Tech for Exchange
North China Electric Power University Foreign Aid Training Program Visits Yiyuan …
On July 23, 2025, the Electrical Industry Training Program of North China Electric Power University's Foreign Aid Project visited Yiyuan Technology for an exchange visit. The purpose was to gain in-depth insights into the company's innovations in renewable energy technology promotion and application [https://www.yiyen.com/about/], and to build bridges connecting university-enterprise cooperation with foreign aid initiatives. Image: https://ecdn6.globalso.com/upload/p/1108/image_other/2025-07/scene-1.jpg Image: https://ecdn6.globalso.com/upload/p/1108/image_other/2025-07/scene-3.jpg Upon arrival, the delegation received a warm welcome from company leadership and the reception
Pure Sine Wave Low Frequency Inverter Charger
Pure Sine Wave Low Frequency Inverter Charger
Pure sine wave low frequency inverter [https://www.yiypower.com/ap-mini-600w-1500w-120v-low-frequency-pure-sine-wave-inverter-charger-product/] is widely used and suitable for a variety of scenarios. In terms of home backup power, it can provide reliable power during power outages, ensuring that essential appliances such as refrigerators, air conditioners and medical equipment continue to operate . For solar power generation systems, Inverter charger [https://www.yiypower.com/ap-mini-600w-1500w-120v-low-frequency-pure-sine-wave-inverter-charger-product/] can converter DC Power from Battery, which charged by solar panels, into clean alternating current

All 5 Releases


More Releases for Hepatic

Top Trends Transforming the Hepatic Encephalopathy Market Landscape in 2025: Inn …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts What Will the Hepatic Encephalopathy Industry Market Size Be by 2025? The market size for hepatic encephalopathy has witnessed significant expansion in the past few years. The market, projected to rise from $1.72 billion in 2024 to $1.8 billion in 2025, is estimated to have a compound annual growth
Liver Disease Treatment Market: Advancing Hepatic Care
The liver disease treatment market encompasses a range of medications, therapies, and procedures aimed at managing and curing liver conditions such as hepatitis, fatty liver disease, cirrhosis, liver cancer, and liver failure. Given the liver's critical role in metabolic processes, detoxification, and protein synthesis, effective treatment options are essential for maintaining overall health. The market is influenced by factors such as the rising prevalence of liver diseases, advancements in medical
Hepatic Encephalopathy Treatment Market - Transforming hepatic encephalopathy ca …
Newark, New Castle, USA: The "Hepatic Encephalopathy Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Hepatic Encephalopathy Treatment Market: https://www.growthplusreports.com/report/hepatic-encephalopathy-treatment-market/8818 This latest report researches the industry structure,
Hepatic Encephalopathy Treatment Market - Driving Progress, Inspiring Hope: Lead …
Newark, New Castle, USA - new report, titled Hepatic Encephalopathy Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatic Encephalopathy Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatic Encephalopathy Treatment market. The report offers an overview of
Hepatic Biomarkers Market Size & Analysis - Forecast to 2026
The findings reviewed by GME stated that the Global Hepatic Biomarkers Market will grow at a CAGR value of 6.5% from 2021 to 2026. The increasing prevalence of chronic diseases, like cancers and other chronic diseases, is raising the use of hepatic biomarkers all over the world. Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Global Hepatic Biomarkers Market - Forecast to 2026"
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2017
"The Report Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2017, provides an overview of the Liver Failure (Hepatic Insufficiency) (Gastrointestinal) pipeline landscape. Liver failure is severe deterioration of liver function. Liver failure occurs when